Mariana Lemos Rizzardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mariana Lemos Rizzardi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anderson Matheus Oliveira Haas Verdi
Postgraduate Program in Nutrition, Federal University of São Paulo (UNIFESP), Baixada Santista Campus, Santos 11015-020, Brazil
1 shared publication - Dalton Luiz Schiessel
Universidade Estadual do Centro-Oeste - UNICENTRO
1 shared publication - Daniela Caetano Gonçalves
Department of Biosciences, Federal University of São Paulo (UNIFESP), Baixada Santista Campus, Santos 11015-020, Brazil
1 shared publication - Dario Coletti
Unit of Histology and Medical Embryology, Department of Anatomy, Histology, Forensic Medicine and Orthopedics, Sapienza University of Rome, 00161 Roma, Italy
1 shared publication - Jaqueline Machado Soares
Universidade Estadual do Centro-Oeste
1 shared publication - Marília Seelaender
Universidade de São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
Nutraceutical Interception of Cachexia: Grape-Derived Compounds as Pathophysiological Network Modulators
Cancer cachexia is a multifactorial syndrome characterized by metabolic dysregulation, inflammation, and progressive loss of skeletal muscle mass. Frequently observed in colorectal cancer patients, it is associated with poor clinical outcomes and reduced treatment tolerance. Current therapies provide limited benefit, underscoring the need for integrative approaches. Grape seed polyphenols, particularly oligomeric proanthocyanidins, have demonstrated potential to modulate catabolic signaling, mitochondrial dysfunction, and inflammatory responses involved in cachexia pathophysiology. This review integrates preclinical and clinical evidence on the use of grape seed-derived products, highlighting their effects on NF-κB and AMPK pathways, redox homeostasis, and gut–muscle axis. Furthermore, the nutritional composition and bioactive properties of grape seed flour—rich in fiber and phenolic compounds—are discussed in the context of nutraceutical applications. A clinical trial currently underway in Brazil aims to evaluate the effects of grape seed flour supplementation in colorectal cancer patients with cachexia. Altogether, grape-derived compounds offer a safe, low-cost, and mechanistically grounded strategy for improving nutritional status and resilience in oncological care.
Open AccessNutraceutical Interception of Cachexia: Grape-Derived Compounds as Pathophysiological Network Modulators
Cancer cachexia is a multifactorial syndrome characterized by metabolic dysregulation, inflammation, and progressive loss of skeletal muscle mass. Frequently observed in colorectal cancer patients, it is associated with poor clinical outcomes and reduced treatment tolerance. Current therapies provide limited benefit, underscoring the need for integrative approaches. Grape seed polyphenols, particularly oligomeric proanthocyanidins, have demonstrated potential to modulate catabolic signaling, mitochondrial dysfunction, and inflammatory responses involved in cachexia pathophysiology. This review integrates preclinical and clinical evidence on the use of grape seed-derived products, highlighting their effects on NF-κB and AMPK pathways, redox homeostasis, and gut–muscle axis. Furthermore, the nutritional composition and bioactive properties of grape seed flour—rich in fiber and phenolic compounds—are discussed in the context of nutraceutical applications. A clinical trial currently underway in Brazil aims to evaluate the effects of grape seed flour supplementation in colorectal cancer patients with cachexia. Altogether, grape-derived compounds offer a safe, low-cost, and mechanistically grounded strategy for improving nutritional status and resilience in oncological care.